StreetInsider.com News Articles

Form SD RxSight, Inc.

Fri, 29 May 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260529/26576668.html

Form SD RxSight, Inc.

Fri, 29 May 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260529/26576668.html

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

Tue, 19 May 2026 16:10:00 -0400

ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in a fireside chat on Tuesday, May 26, 2026, at 10:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system,

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

Tue, 19 May 2026 16:10:00 -0400

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system,

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

Tue, 19 May 2026 16:10:00 -0400

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system,

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

Tue, 19 May 2026 16:10:00 -0400

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system,

Form SCHEDULE 13G/A RxSight, Inc. Filed by: Artisan Partners Limited Partnership

Wed, 13 May 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260513/26481429.html

Form SCHEDULE 13G/A RxSight, Inc. Filed by: Artisan Partners Limited Partnership

Wed, 13 May 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260513/26481429.html

RxSight Inc. (RXST) PT Lowered to $9 at Wells Fargo

Thu, 07 May 2026 08:23:59 -0400

Wells Fargo analyst Larry Biegelsen lowered the price target on RxSight Inc. (NASDAQ: RXST) to $9.00 (from $11.00) while maintaining a Equal Weight rating.

RxSight Inc. (RXST) PT Lowered to $8 at Stifel

Thu, 07 May 2026 08:20:53 -0400

Stifel analyst Tom Stephan lowered the price target on RxSight Inc. (NASDAQ: RXST) to $8.00 (from $9.00) while maintaining a Hold rating.

RxSight Inc. (RXST) PT Lowered to $11 at Needham

Thu, 07 May 2026 07:24:07 -0400

Needham analyst David Saxon lowered the price target on RxSight Inc. (NASDAQ: RXST) to $11.00 (from $13.00) while maintaining a Buy rating.

RxSight, Inc. (RXST) Tops Q1 EPS by 12c

Wed, 06 May 2026 16:30:57 -0400

RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.19), $0.12 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $29.75 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

Form 10-Q RxSight, Inc. For: Mar 31

Wed, 06 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260506/26443617.html

Form 10-Q RxSight, Inc. For: Mar 31

Wed, 06 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260506/26443617.html

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

Wed, 06 May 2026 16:05:00 -0400

ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026.

Strategic Highlights and Recent Developments

Q1 sales of $30.9 million driven by 27,472 Light Adjustable Lens (LAL) units
20 Light Delivery Devices (LDDs) sold in Q1, expanding the installed base to 1,154 units
Robust clinical data presented at the recent American Society of Cataract and Refractive Surgery (ASCRS) annual meeting highlighting the versatility and impact of adjustability
Recent regulatory approval in New Zealand furthering the company’s international footprint and global

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

Wed, 06 May 2026 16:05:00 -0400

ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026.

Strategic Highlights and Recent Developments

Q1 sales of $30.9 million driven by 27,472 Light Adjustable Lens (LAL) units
20 Light Delivery Devices (LDDs) sold in Q1, expanding the installed base to 1,154 units
Robust clinical data presented at the recent American Society of Cataract and Refractive Surgery (ASCRS) annual meeting highlighting the versatility and impact of adjustability
Recent regulatory approval in New Zealand furthering the company’s international footprint and global

Form 8-K RxSight, Inc. For: May 06

Wed, 06 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260506/26443400.html

Form 8-K RxSight, Inc. For: May 06

Wed, 06 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260506/26443400.html

Form ARS RxSight, Inc. For: Dec 31

Tue, 28 Apr 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260428/26384757.html

Form ARS RxSight, Inc. For: Dec 31

Tue, 28 Apr 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260428/26384757.html

Form DEFA14A RxSight, Inc.

Tue, 28 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260428/26384722.html

Form DEFA14A RxSight, Inc.

Tue, 28 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260428/26384722.html

Form DEF 14A RxSight, Inc. For: Apr 27

Tue, 28 Apr 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260428/26384654.html

Form DEF 14A RxSight, Inc. For: Apr 27

Tue, 28 Apr 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260428/26384654.html

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

Wed, 22 Apr 2026 16:10:00 -0400

ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

To participate in the conference call, please dial (800) 715-9871 or (646) 307-1963, and enter the conference code: 2630350. The call will also be broadcast live in listen-only mode via a link on the company’s investor relations website at